Headache (frequency) · people with episodic migraine
2 findings from 1 review
Response (after treatment) · people with episodic migraine
Acupuncture probably leads to higher response (after treatment) compared with sham interventions (moderate certainty).
1 finding from 1 review
Response ( · people with episodic migraine
Acupuncture probably leads to higher response ( compared with sham interventions (moderate certainty).
1 finding from 1 review
Adverse effects (drop‐outs due to adverse effects4) · people with episodic migraine
Acupuncture showed no clear difference in number of participants dropping out due to adverse effects compared with sham interventions (low certainty).
1 finding from 1 review
Global state: not improved ‐ short‐term GAF · patients with schizophrenia
It is very uncertain whether ACUPUNCTURE changes global state: Not improved (talk, behaviour and expression still… compared with STANDARD DOSE ANTIPSYCHOTICS (very low certainty).
1 finding from 1 review
Behaviour: Leaving the study early (short‐term) · patients with schizophrenia
1 finding from 1 review
Service outcomes: Hospitalisation · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
Adverse effects: any observed extrapyramidal symptoms ‐ short term (up to 6 months) · patients with schizophrenia
ACUPUNCTURE may leads to lower adverse effects: Extrapyramidal symptoms (short‐term) compared with STANDARD DOSE ANTIPSYCHOTICS (low certainty).
1 finding from 1 review
Quality of life: No clinically important change in quality of life · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
Economic outcomes: Cost of care · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
Clinical response: no clinically significant response in mental state · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
Behaviour: Leaving the study early (short‐term) · patients with schizophrenia
1 finding from 1 review
Service outcomes: Hospitalisation · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
Adverse effects: Clinically important general adverse effect (no data) · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
Quality of life: No clinically important change in quality of life · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
Economic outcomes: Cost of care · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
Pain up to 1 month after treatment VAS2 · patients with fibromyalgia
1 finding from 1 review
Physical function · patients with fibromyalgia
The review found no eligible studies for this question.
1 finding from 1 review
Global well‐being: rated by participants · patients with fibromyalgia
The review found no eligible studies for this question.
1 finding from 1 review
Sleep · patients with fibromyalgia
The review found no eligible studies for this question.
1 finding from 1 review